Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transaminase Engineering. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106399418B reveals a transaminase route for moxifloxacin intermediates. Achieve >99% ee and reduced costs with our scalable biocatalytic manufacturing solutions.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Patent CN116004562A reveals a quadruple transaminase mutant boosting D-4,4'-biphenylalanine production efficiency by 30-fold, offering a scalable, high-purity solution for LCZ696 intermediates.
Patent CN114657164B reveals a novel enzymatic route for L-glufosinate, offering superior purity and cost efficiency for agrochemical intermediate supply chains.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.